• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MD Anderson selects Oracle applications and tech to help transform cancer care

MD Anderson selects Oracle applications and tech to help transform cancer care

February 1, 2013
CenterWatch Staff

The University of Texas MD Anderson Cancer Center, a center devoted exclusively to cancer patient care, research, education and prevention, has selected Oracle Health Sciences applications and Oracle technology as the foundation for an organization-wide analytics initiative designed to enable a new generation of personalized cancer treatment that improves outcomes. 

The platform will also support the center’s Moon Shots Program, an effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Oracle applications and technology will power the enterprise analytics initiative, one of the program’s platforms. The new platform will bring together clinical, genomic, financial, administrative and operational information from internal and external sources to yield insights that drive care innovation and optimize operational efficiency.

“As we focus on the next-generation of treatments—including our Moon Shots Program—we require a powerful analytical infrastructure that can yield new insight from the unprecedented volume of data available today,” said Dr. John Frenzel, chief medical information officer, MD Anderson. “Oracle’s integrated health sciences applications, enterprise applications and technology stack will help provide one of the robust foundations that we need to accelerate deployment, and ultimately, discovery of life-saving treatments.”

To achieve its goals, MD Anderson will deploy a wide range of Oracle solutions, including Oracle Enterprise Healthcare Analytics. The center, which sees data growth of 30%-40% annually, is also deploying Oracle Database and Oracle Business Intelligence Enterprise Edition.

“Leveraging data and information to drive more effective resource utilization, improve operational efficiency and level patient volumes across the days of the week is becoming increasingly more important,” said Craig Owen, director of clinical analytics and informatics, MD Anderson. “Through the use of Oracle Enterprise Healthcare Analytics, we are creating the platform to improve delivery of actionable information to our customers so they can effectively improve processes.”

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing